Drug Patents Expiring in 2014
1. Abilify Maintena Kit patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5006528 | OTSUKA PHARM CO LTD | Carbostyril derivatives |
Oct, 2014
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Dosage Form(NDF) | Feb 28, 2016 |
| M(M-150) | Dec 05, 2017 |
| New Indication(I-746) | Jul 27, 2020 |
Drugs and Companies using ARIPIPRAZOLE ingredient
Market Authorisation Date: 28 February, 2013
Treatment: Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia
Dosage: FOR SUSPENSION, EXTENDED RELEASE
How can I launch a generic of ABILIFY MAINTENA KIT before it's drug patent expiration?
More Information on Dosage
ABILIFY MAINTENA KIT family patents
2. Copaxone patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6362161 | TEVA PHARMS USA | Copolymer-1 improvements on compositions of copolymers |
May, 2014
(10 years ago) | |
| US7199098 | TEVA PHARMS USA | Copolymer-1 improvements in compositions of copolymers |
May, 2014
(10 years ago) | |
| US6054430 | TEVA PHARMS USA | Copolymer-1 improvements in compositions of copolymers |
May, 2014
(10 years ago) | |
| US8367605 | TEVA PHARMS USA | Copolymer-1 improvements in compositions of copolymers |
May, 2014
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-594) | Feb 27, 2012 |
| New Product(NP) | Jan 28, 2017 |
Drugs and Companies using GLATIRAMER ACETATE ingredient
Market Authorisation Date: 20 December, 1996
Treatment: NA
Dosage: INJECTABLE
How can I launch a generic of COPAXONE before it's drug patent expiration?
More Information on Dosage
COPAXONE family patents
3. Minivelle patent
expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5656286 | NOVEN | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Aug, 2014
(10 years ago) | |
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 23 September, 2014
Treatment: NA
Dosage: FILM, EXTENDED RELEASE
How can I launch a generic of MINIVELLE before it's drug patent expiration?
More Information on Dosage
MINIVELLE family patents
4. Nexium 24hr patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6875872 | ASTRAZENECA LP | Compounds |
May, 2014
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| RTO(RTO) | Mar 28, 2017 |
Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient
Market Authorisation Date: 28 March, 2014
Treatment: NA
Dosage: CAPSULE, DELAYED RELEASE
How can I launch a generic of NEXIUM 24HR before it's drug patent expiration?
More Information on Dosage
NEXIUM 24HR family patents
5. Novolog Flextouch patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5618913 | NOVO NORDISK INC | Insulin analogues |
Jun, 2014
(10 years ago) | |
Drugs and Companies using INSULIN ASPART RECOMBINANT ingredient
Market Authorisation Date: 31 October, 2013
Treatment: NA
Dosage: INJECTABLE
More Information on Dosage
NOVOLOG FLEXTOUCH family patents
6. Noxafil patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5703079 | MERCK SHARP DOHME | Tetrahydrofuran antifungals |
Aug, 2014
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Sep 15, 2011 |
| New Patient Population(NPP) | May 31, 2024 |
| New Indication(I-881) | Jun 17, 2024 |
| Orphan Drug Exclusivity(ODE-355) | Jun 17, 2028 |
Drugs and Companies using POSACONAZOLE ingredient
Market Authorisation Date: 25 November, 2013
Treatment: Prophylaxis of invasive aspergillus and candida infections
Dosage: TABLET, DELAYED RELEASE; SOLUTION
How can I launch a generic of NOXAFIL before it's drug patent expiration?
More Information on Dosage
NOXAFIL family patents
7. Varithena patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| USRE38919 | PROVENSIS | Injectable microfoam containing a sclerosing agent |
Oct, 2014
(10 years ago) | |
Drugs and Companies using POLIDOCANOL ingredient
Market Authorisation Date: 21 December, 2017
Treatment: NA
Dosage: SOLUTION
More Information on Dosage
VARITHENA family patents